Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2016

Open Access 01-12-2016 | Research article

The use of a multiple imputation method to investigate the trends in Histologic types of lung cancer in Songkhla province, Thailand, 1989–2013

Authors: Hutcha Sriplung, Seesai Yeesoonsang, Edward McNeil, Surichai Bilheem

Published in: BMC Cancer | Issue 1/2016

Login to get access

Abstract

Background

The incidence of lung cancer in many parts of the country as shown in cancer registry statistics is not decreasing. The incidence of adenocarcinoma (ADCA) in Songkhla is now higher than that of squamous cell carcinoma (SCC) in both sexes. The percentage of the unknown histologic type of lung cancer in Songkhla is around 30 %. The objective of this study is to estimate trends in incidence of the two major histologic types of lung cancer: SCC and ADCA, in Songkhla province of Thailand from 1989 to 2013.

Methods

Age-standardized incidence rates (ASR) were used to compare and described the trends in both major types of cancers. Multinomial logistic regression models were used to impute unknown histological cancer types using a multiple imputation (MI) method to account for the high percentage of unknown histology.

Results

The multinomial predictive model for major types of lung cancer in Songkhla consisted of sex, age, year of diagnosis, and place of residence. After MI, the number of cases with both SCC and ADCA in both sexes increased by one-third of the number of cases with originally known histology. The increasing trends were observed in ADCA in both sexes while SCC in males was stable and in females was decreasing.

Conclusions

A rapid increase in the incidence of ADCA was found while the incidence of SCC in males showed no significant change and it was declining in females. These results warrant an investigation into risk factors other than cigarette smoking. The number of cases has limited use when the age structure of the population under study is changing. Year of diagnosis was one of the predictors in the MI model.
Literature
1.
Sriplung H, Wiangnon S, Sontipong S, Sumitsawan Y, Martin N. Cancer incidence trends in Thailand, 1989–2000. Asian Pac J Cancer Prev. 2006;7(2):239–44.PubMed
2.
Khuhaprema T, Attasara P, Sriplung H, Wiangnon S, Sangrajrang S. Cancer in Thailand. Vol VII, 2007–2009. Bangkok: National Cancer Institute; 2013.
3.
Lortet-Tieulent J, Soerjomataram I, Ferlay J, Rutherford M, Weiderpass E, Bray F. International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women. Lung Cancer. 2014;84(1):13–22.CrossRefPubMed
4.
5.
Sriplung H, Sontipong S, Martin N, Wiangnon S, Vootiprux V, Cheirsilpa A, et al. Cancer Incidence in Thailand, 1995–1997. Asian Pac J Cancer Prev. 2005;6:276–81.PubMed
6.
Moore MA, Attasara P, Khuhaprema T, Le TN, Nguyen TH, Raingsey PP, et al. Cancer epidemiology in mainland South-East Asia - past, present and future. Asian Pac J Cancer Prev. 2010;11 Suppl 2:67–80.PubMed
7.
Vatanasapt V, Martin N, Sriplung H, Chindavijak K, Sontipong S, Sriamporn H, et al. Cancer incidence in Thailand, 1988–1991. Cancer Epidemiol Biomarkers Prev. 1995;4(5):475–83.PubMed
8.
Caldarella A, Crocetti E, Comin CE, Janni A, Pegna AL, Paci E. Gender differences in non-small cell lung cancer: a population-based study. Eur J Surg Oncol. 2007;33(6):763–8.CrossRefPubMed
9.
Raz DJ, Gomez SL, Chang ET, Kim JY, Keegan THM, Pham J, et al. Epidemiology of non-small cell lung cancer in Asian Americans: incidence patterns among six subgroups by nativity. J Thorac Oncol. 2008;3(12):1391–7.CrossRefPubMed
10.
Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc. 2011;8(5):381–5.CrossRefPubMed
11.
Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6(2):244–85.CrossRefPubMedPubMedCentral
12.
13.
Carpenter J, Kenward MG, editors. Multiple Imputation and Its Application (Statistics in Practice). West Sussex: Wiley; 2013.
14.
15.
International Association of Cancer Registries. International rules for multiple primary cancers. Asian Pac J Cancer Prev. 2005;6(1):104–6.
16.
National Statistical Office. Advance Report: 1990 Population and Housing Census. Bangkok, Thailand: National Statistical Office; 1992.
17.
18.
19.
Office of the National Economic and Social Development Board. Population Projections for Thailand 2010-2040. Bangkok, Thailand: 2013.
20.
21.
22.
Agresti A. Categorical Data Analysis. 2nd ed. New Jersey: John Wiley & Sons, Inc.; 2002.CrossRef
23.
White IR, Daniel R, Royston P. Avoiding bias due to perfect prediction in multiple imputation of incomplete categorical variables. Comput Stat Data Anal. 2010;54(10):2267–75.CrossRefPubMedPubMedCentral
24.
Doll R, Payne P, Waterhouse JAH. Cancer Incidence in Five Continents, Vol. I. Geneva: Union Internationale Contre le Cancer; 1966.CrossRef
25.
Segi M. Cancer mortality for selected sites in 24 countries (1950–57). Sendai: Department of Public Health, Tohoku University of Medicine; 1960.
26.
27.
28.
R Core Team. R: A language and environment for statistical computing [Internet]. Vienna: R Foundation for Statistical Computing. 2015. http://​www.​R-project.​org/​
29.
Cheng I, Le GM, Noone A-M, Gali K, Patel M, Haile RW, et al. Lung cancer incidence trends by histology type among Asian American, Native Hawaiian, and Pacific Islander populations in the United States, 1990–2010. Cancer Epidemiol Biomarkers Prev. 2014;23(11):2250–65.CrossRefPubMed
30.
Houston KA, Henley SJ, Li J, White MC, Richards TB. Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004–2009. Lung Cancer. 2014;86(1):22–8.CrossRefPubMed
31.
32.
Seow A, Duffy SW, Ng TP, McGee MA, Lee HP. Lung cancer among Chinese females in Singapore 1968–1992: time trends, dialect group differences and implications for aetiology. Int J Epidemiol. 1998;27(2):167–72.CrossRefPubMed
33.
34.
Yoshimi I, Ohshima A, Ajiki W, Tsukuma H, Sobue T. A comparison of trends in the incidence rate of lung cancer by histological type in the Osaka Cancer Registry, Japan and in the Surveillance, Epidemiology and End Results Program, USA. Jpn J Clin Oncol. 2003;33(2):98–104.CrossRefPubMed
35.
Tse LA, Mang OW-K, Yu IT-S, Wu F, Au JS-K, Law SC-K. Cigarette smoking and changing trends of lung cancer incidence by histological subtype among Chinese male population. Lung Cancer. 2009;66(1):22–7.CrossRefPubMed
36.
Al-Hashimi MMY, Wang XJ. Trend analysis of lung cancer incidence rates in ninawa province, Iraq, from 2000 to 2010--decrease and recent stability. Asian Pac J Cancer Prev. 2014;15(1):385–90.CrossRefPubMed
37.
Barzi F, Woodward M. Imputations of missing values in practice: results from imputations of serum cholesterol in 28 cohort studies. Am J Epidemiol. 2004;160(1):34–45.CrossRefPubMed
38.
Souverein OW, Zwinderman AH, Tanck MWT. Multiple imputation of missing genotype data for unrelated individuals. Ann Hum Genet. 2006;70(Pt 3):372–81.PubMed
39.
Yamamoto S, Sobue T, Yamaguchi N, Yamamoto S, Kikui M, Kusunoki Y, et al. Reproducibility of diagnosis and its influence on the distribution of lung cancer by histologic type in Osaka, Japan. Jpn J Cancer Res. 2000;91(1):1–8.CrossRefPubMed
Metadata
Title
The use of a multiple imputation method to investigate the trends in Histologic types of lung cancer in Songkhla province, Thailand, 1989–2013
Authors
Hutcha Sriplung
Seesai Yeesoonsang
Edward McNeil
Surichai Bilheem
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2016
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-016-2441-8

Other articles of this Issue 1/2016

BMC Cancer 1/2016 Go to the issue

Research article

Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi’s sarcoma in five countries across sub-Saharan Africa

Research article

Follow-up practices for high-grade extremity Osteosarcoma

Research article

Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma

Research article

Hypoxic resistance of KRAS mutant tumor cells to 3-Bromopyruvate is counteracted by Prima-1 and reversed by N-acetylcysteine

Research article

Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells

Research article

Feasibility outcomes of a presurgical randomized controlled trial exploring the impact of caloric restriction and increased physical activity versus a wait-list control on tumor characteristics and circulating biomarkers in men electing prostatectomy for prostate cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits